ESC

This channel contains news about the European Society of Cardiology (ESC), including coverage of its annual meeting and new guidelines. ESC is a leading resource for cardiology science and information in Europe.

Research presented at ESC Congress 2022 supports a causal relationship between air pollution and heart attacks since smokers, who already inhale smoke, were unaffected by dirty air.

News | Stroke

Air Pollution is Associated with Heart Attacks in Non-Smokers

September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...

September 06, 2022

BOX trial presented in a Hot Line Session at ESC Congress 2022

News | Sudden Cardiac Arrest

Restrictive Oxygenation in Post Cardiac Arrest Patients is Not Harmful

September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...

September 02, 2022

DELIVER trial presented in a Hot Line Session at ESC Congress 2022

News | Heart Failure

Dapagliflozin Benefits Patients with Mildly Reduced and Preserved Ejection Fraction

September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...

September 02, 2022

ADVOR trial presented in a Hot Line Session at ESC Congress 2022

News | Heart Failure

Acetazolamide Improves Decongestion in Patients with Acute Decompensated Heart Failure

September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...

September 02, 2022

DANCAVAS trial presented in a Hot Line Session at ESC Congress 2022

News | Cardiac Imaging

Cardiovascular Screening May Reduce Risk of Death and Cardiovascular Disease

September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including car ...

September 02, 2022

DANFLU-1 trial presented in a Hot Line Session at ESC Congress 2022

News | Cardiac Imaging

Innovative Randomized Trial Hints at Mortality Benefits with High-Dose Influenza Vaccines

September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...

September 02, 2022

News | Artificial Intelligence

Artificial Intelligence Assessment of Heart Function is Superior to Sonographer Assessment

September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by a ...

September 02, 2022

REVIVED-BCIS2 trial presented in a Hot Line Session today at ESC Congress 2022

News | Heart Failure

Coronary Stenting Does Not Benefit Patients with Severe Left Ventricular Dysfunction

September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospit ...

September 02, 2022

More than 30,271 health professionals from 174 countries attended this year’s event, which covered the entire field of cardiovascular medicine at ESC22

News | ESC

Best of ESC Congress 2022

September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...

September 01, 2022

Comatose patients admitted to hospital after resuscitation from out-of-hospital cardiac arrest have a significant risk of death and poor neurological outcome due to hypoxic brain injury.

News | Sudden Cardiac Arrest

Trial Finds no Benefit of Raising Blood Pressure Target in Post Cardiac Arrest Patients

September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...

September 01, 2022

ALL-HEART trial presented in a Hot Line Session at ESC Congress 2022

News | Stroke

Allopurinol Does Not Improve Cardiovascular Outcomes in Ischaemic Heart Disease Patients

September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...

September 01, 2022

A clinician using Ultrasound Workspace from Philips

News | ESC

Philips Spotlights Integrated, Data-Driven Cardiology Solutions at ESC 2022

August 30, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest ...

August 30, 2022

SECURE trial presented in a Hot Line Session today at ESC Congress 2022

News | ESC

Polypill Reduces Cardiovascular Events in Heart Attack Patients Compared to Usual Care

August 30, 2022 — A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents ...

August 30, 2022

The MOMENTUM 3 study showcases the significant survival benefits of Abbott's heart pump technology, particularly in a patient population with limited therapy options

News | ESC

New Data Show Abbott's Heartmate 3 Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients

August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of advan ...

August 30, 2022

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success

News | Heart Failure

FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial

August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...

August 29, 2022